Cordis, the interventional vascular arm of Cardinal Health, has announced three new additions to its cardiology portfolio for use in Europe, the Middle East, and Africa. The new products were on show at EUROPCR 2017 in Paris this week and include the RAILWAY Sheathless Access System and two new percutaneous transluminal coronary angioplasty (PCTA) balloon catheters: the Ikazuchi Zero and Raiden3 under the Kaneka brand name.
The RAILWAY Sheathless Access System is indicated for radial artery use and allows direct access to the artery for introducing intravascular devices. The system completely eliminates the need for an introducer sheath and is optimized for use with ADROIT and VISTA BRITE TIP guide catheters, resulting in a two-French reduction in system size. The system is also compatible with other Cordis 5F, 6F, and 7F guide catheters across all shapes, including dedicated radial shapes.
In October 2016, Cardinal Health entered into a distribution agreement with manufacturer Kaneka, giving Cordis access to the Japanese balloon catheters. The new balloon catheter offerings have received CE mark approval, and are suitable for treating smaller and narrower legions in both everyday and complex PTCA cases. The Ikazuchi Zero catheter represents the lowest-profile 1.0mm diameter pre-dilation balloon available and features a new coating to improve trackability. The Raiden3 system offers improved inflation accuracy, even after repeated inflation/deflation cycles, and also boasts a 22atm rated burst pressure, one of the highest ratings on the market.
Via: Cardinal Health…